3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Neuroblastoma
9
Melanoma
4
Ganglioneuroblastoma
4
Triple Negative Breast Neoplasms
3
Lung Neoplasms
3
Carcinoma, Non-Small-Cell Lung
2
Adenoma, Islet Cell
2
Uveal Melanoma
1
Uterine Cervical Neoplasms
1
Transplant-Related Hematologic Malignancy
1
Squamous Cell Carcinoma of Head and Neck
1
Sarcoma, Alveolar Soft Part
1
Recurrence
1
Prostatic Neoplasms
1
Pathologic Complete Response
1
Neoplasms
1
Neoplasm Metastasis
1
Multiple Myeloma
1
Lymphoma, Large-Cell, Anaplastic
1
Lymphoma
1
Locally Advanced Pancreatic Adenocarcinoma
1
Leukemia, Plasma Cell
1
Leukemia, Myeloid, Acute
1
Leukemia
1
Hodgkin Disease
1
Gliosarcoma
1
Glioblastoma
1
Endometrial Neoplasms
1
Carcinosarcoma
1
Carcinoma, Transitional Cell
1
Interventions
Dexamethasone
13
daratumumab
7
Bortezomib
7
Cyclophosphamide
6
Calcium Dobesilate
5
ixazomib
4
dexamethasone acetate
4
dexamethasone 21-phosphate
4
auricularum
4
venetoclax
3
belantamab mafodotin
3
Specimen Handling
3
4-(N-methylamino)-4'-(2-(2-(2-fluoroethoxy)ethoxy)ethoxy)stilbene
3
pomalidomide
2
isatuximab
2
X-Rays
2
Polymerase Chain Reaction
2
Phantoms, Imaging
2
Magnetic Resonance Spectroscopy
2
Clinical Protocols
2
Biopsy
2
siltuximab
1
Valganciclovir
1
Tissue Banks
1
Therapeutics
1
Stem Cell Transplantation
1
Spectrometry, Fluorescence
1
Positron-Emission Tomography
1
Pharmaceutical Preparations
1
Melphalan
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Immunoglobulin Light-chain Amyloidosis
×
sargramostim
×
1 year
×
Clear all
No trials found.